The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Pharmaceutical industry sponsorship and research outcome and quality: systematic review
Lexchin, J., Bero, L. A., Djulbegovic, B., & Clark, O. (2003) · BMJ · doi:10.1136/bmj.326.7400.1167 · Cited by 2,147
Confidence intervals for the number needed to treat.
Altman, D. G. (1998) · BMJ · doi:10.1136/bmj.317.7168.1309 · Cited by 938
KELLER, M. B., RYAN, N. D., STROBER, M., KLEIN, R. G., KUTCHER, S. P., BIRMAHER, B., HAGINO, O. R., KOPLEWICZ, H., CARLSON, G. A., CLARKE, G. N., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200107000-00010 · Cited by 641
Research works printed but not linked: 18
- Costello, 1996, The Great Smoky Mountains Study of Youth: goals, design, methods, and the prevalence of DSM-III-R disorders, Arch Gen Psychiatry, 53, 1129, 10.1001/archpsyc.1996.01830120067012 · DOI · Paper page
- Costello, 1989, Developments in child psychiatric epidemiology, J Am Acad Child Adolesc Psychiatry, 28, 836, 10.1097/00004583-198911000-00004 · DOI · Paper page
- Anderson, 2002, Deaths: leading causes for 2000, Natl Vital Stat Rep, 50, 1
- Lewinsohn, 1999, Psychosocial treatments for adolescent depression, Clin Psychol Rev, 19, 329, 10.1016/S0272-7358(98)00055-5 · DOI
- Hazell, 2004, Tricyclic drugs for depression in children and adolescents (Cochrane Review)
- Garland, 2004, Facing the evidence: antidepressant treatment in children and adolescents, CMAJ, 170, 489
- Herxheimer, 2004, Antidepressants and adverse effects in young patients: uncovering the evidence, CMAJ, 170, 487
- Kondro, 2004, Drug company experts advised staff to withhold data about SSRI use in children, CMAJ, 170, 783, 10.1503/cmaj.1040213 · DOI
- Melander, 2003, Evidence b(i)ased medicine: selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications, BMJ, 326, 1171, 10.1136/bmj.326.7400.1171 · DOI · Paper page
- Ramchandani, 2004, Treatment of major depressive disorder in children and adolescents: most selective serotonin reuptake inhibitors are no longer recommended, BMJ, 328, 3, 10.1136/bmj.328.7430.3 · DOI
- McPherson, 2004, Synthesising licensing data to assess drug safety, BMJ, 328, 518, 10.1136/bmj.328.7438.518 · DOI
- Review Manager (RevMan) [Computer program], 2003
- Emslie, 1997, A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression, Arch Gen Psychiatry, 54, 1031, 10.1001/archpsyc.1997.01830230069010 · DOI · Paper page
- Emslie, 2002, Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial, J Am Acad Child Adolesc Psychiatry, 41, 1205, 10.1097/00004583-200210000-00010 · DOI · Paper page
- Wagner, 2003, Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials, JAMA, 290, 1033, 10.1001/jama.290.8.1033 · DOI · Paper page
- Mandoki, 1997, Venlafaxine in the treatment of children and adolescents with major depression, Psychopharmacol Bull, 33, 149
- Wagner, 2003, Remission status after long-term sertraline treatment of pediatric obsessive-compulsive disorder, J Child Adolesc Psychopharmacol, 13, S53, 10.1089/104454603322126340 · DOI
- Kapczinski, 2004, Antidepressants for generalized anxiety disorder (Cochrane Review)
Cited by
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
“now require all clinical trials to be registered in an effort to increase transparency and accountability.”
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.005 · Cited by 19,575
Metadata
- Authors
- Whittington, C. J., Kendall, T., Fonagy, P., Cottrell, D., Cotgrove, A., & Boddington, E.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2004-04
- Volume
- 363
- Issue
- 9418
- Pages
- 1341-1345
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2098631889
- Cited by
- 1,058
- References
- 4
- FWCI
- 11.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. https://app.cochat.ai/papers/10.1016/s0140-6736(04)16043-1
- The paper
- Whittington, C. J., Kendall, T., Fonagy, P., Cottrell, D., Cotgrove, A., & Boddington, E. (2004). Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. The Lancet. https://doi.org/10.1016/s0140-6736(04)16043-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
